Overlapping anti-NMDAR encephalitis and multiple sclerosis: A case report and literature review

Pan Liu,Hui Yan,Haizhe Li,Chunhua Zhang,Yanfang Li
DOI: https://doi.org/10.3389/fimmu.2023.1088801
IF: 7.3
2023-01-31
Frontiers in Immunology
Abstract:Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an autoimmune-mediated disease characterized by complicated neuropsychiatric symptoms and the detection of cerebrospinal fluid antibodies against the GluN1 subunit of the NMDAR. With the proposed clinical method, more anti-NMDAR encephalitis patients have been discovered since its first report. However, anti-NMDAR encephalitis overlapping with multiple sclerosis (MS) is rare. Herein we report a male patient with anti-NMDAR encephalitis who developed MS in mainland China. Furthermore, we summarized the characteristics of patients who were diagnosed with overlapping MS and anti-NMDAR encephalitis in previous studies. Additionally, we pioneered the use of mycophenolate mofetil in immunosuppressive therapy, providing a novel therapeutic alternative for overlapping anti-NMDAR encephalitis and MS.
immunology
What problem does this paper attempt to address?